Fabrication and characterization of unique sustain modified chitosan nanoparticles for biomedical applications

Marwa ElS. Ahmed,Mansoura I. Mohamed,Hanaa Y. Ahmed,Mahmoud M. Elaasser,Nadia G. Kandile
DOI: https://doi.org/10.1038/s41598-024-64017-4
IF: 4.6
2024-06-16
Scientific Reports
Abstract:Chitosan (CS) is a biopolymer that offers a wide range in biomedical applications due to its biocompatibility, biodegradability, low toxicity and antimicrobial activity. Syringaldehyde (1) is a naturally occurring organic compound characterized by its use in multiple fields such as pharmaceuticals, food, cosmetics, textiles and biological applications. Herein, development of chitosan derivative with physicochemical and anticancer properties via Schiff base formation from the reaction of chitosan with sustainable eco-friendly syringaldehyde yielded the (CS-1) derivative. Moreover, in the presence of polyethylene glycol diglycidyl ether (PEGDGE) or sodium tripolyphosphate (TPP) as crosslinkers gave chitosan derivatives (CS-2) and (CS-3NPs) respectively. The chemical structures of the new chitosan derivatives were confirmed using different tools. (CS-3NPs) nanoparticle showed improvement in crystallinity, and (CS-2) derivative revealed the highest thermal stability compared to virgin chitosan. The cytotoxicity activity of chitosan and its derivatives were evaluated against HeLa (human cervical carcinoma) and HEp-2 (Human Larynx carcinoma) cell lines. The highest cytotoxicity activity was exhibited by (CS-3NPs) compared to virgin chitosan against HeLa cell growth inhibition and apoptosis of 90.38 ± 1.46% and 30.3% respectively and IC 50 of 108.01 ± 3.94 μg/ml. From the above results, it can be concluded that chitosan nanoparticle (CS-3NPs) has good therapeutic value as a potential antitumor agent against the HeLa cancer cell line.
multidisciplinary sciences
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to develop new modified chitosan derivatives and their nanoparticles with anticancer activity and evaluate their effects in inhibiting the growth of cancer cells. Specifically, through the Schiff base formation reaction, the study prepared three modified chitosan derivatives (CS - 1), (CS - 2) and (CS - 3NPs) by reacting chitosan with natural and environmentally - friendly vanillin. Among them, (CS - 3NPs) was prepared by cross - linking with sodium tripolyphosphate (TPP), aiming to enhance the physicochemical properties of chitosan, especially to improve its biological activity as a potential antitumor agent. ### Main research contents: 1. **Material synthesis**: - Three modified chitosan derivatives (CS - 1), (CS - 2) and (CS - 3NPs) were prepared by reacting with vanillin and performing microwave irradiation in the presence of different cross - linking agents (PEGDGE or TPP), respectively. 2. **Characterization techniques**: - The newly synthesized chitosan derivatives were characterized using multiple techniques, including FTIR, XRD, SEM, EDX, TEM, DLS, TGA and DSC, etc. 3. **Biological activity evaluation**: - The cytotoxic activities of chitosan and its derivatives against HeLa (human cervical cancer) and HEp - 2 (human laryngeal cancer) cell lines were evaluated. - Special attention was paid to the influence of (CS - 3NPs) on the apoptotic pathway of HeLa cells, and flow cytometry analysis was carried out using Annexin V - FITC and propidium iodide (PI) staining. ### Main findings: - **Physicochemical properties**: - The (CS - 3NPs) nanoparticles showed improved crystallinity. - The (CS - 2) derivative exhibited the highest thermal stability. - **Biological activity**: - (CS - 3NPs) showed the highest cytotoxic activity in inhibiting the growth of HeLa cells and inducing apoptosis, with an IC50 value of 108.01 ± 3.94 µg/ml, a growth inhibition rate of 90.38 ± 1.46% for HeLa cells, and an apoptosis rate of 30.3%. ### Conclusion: - This study successfully developed modified chitosan nanoparticles (CS - 3NPs) with improved physicochemical properties and significant antitumor activity, showing good therapeutic potential, especially in fighting against HeLa cervical cancer cells. These results indicate that modified chitosan nanoparticles are expected to become an effective antitumor drug.